Ventricular hypoplasia
(UMLS:C0852973)
- UMLS ID:
- C0852973
- MeSH ID:
- N/A
Synonym(s)
1.
Ventricular hypoplasia
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Paroxetine | FAERS: 33 | US FAERS | |
| 2 | Ondansetron | FAERS: 15 | US FAERS | |
| 3 | Citalopram | FAERS: 8 | US FAERS | |
| 4 | Zidovudine | FAERS: 8 | OFFSIDES US FAERS | |
| 5 | Fluoxetine | FAERS: 7 | US FAERS | |
| 6 | Sertraline | FAERS: 6 | US FAERS | |
| 7 | Venlafaxine Hydrochloride | FAERS: 6 | US FAERS | |
| 8 | Lamivudine | FAERS: 4 | US FAERS | |
| 9 | Lamotrigine | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Citalopram | FAERS: 3 | US FAERS | |
| 11 | Fingolimod Hydrochloride | FAERS: 3 | US FAERS | |
| 12 | Citalopram | FAERS: 1 | US FAERS | |
| 13 | Fluoxetine | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Insulin Detemir | FAERS: 1 | US FAERS | |
| 15 | Ketoconazole | FAERS: 1 | US FAERS | |
| 16 | Methylergonovine | FAERS: 1 | US FAERS | |
| 17 | Paroxetine | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Piroxicam | FAERS: 1 | US FAERS | |
| 19 | Risperidone | FAERS: 1 | US FAERS | |
| 20 | Tenofovir | FAERS: 1 | OFFSIDES US FAERS | |
| 21 | Acitretin | OFFSIDES | ||
| 22 | Amphetamine | OFFSIDES | ||
| 23 | Buprenorphine | OFFSIDES | ||
| 24 | Chlorprothixene | OFFSIDES | ||
| 25 | Desonide | OFFSIDES | ||
| 26 | Didanosine | OFFSIDES | ||
| 27 | Leflunomide | OFFSIDES | ||
| 28 | Mebendazole | OFFSIDES | ||
| 29 | Mianserin | OFFSIDES | ||
| 30 | Nelfinavir | OFFSIDES | ||
| 31 | Nicardipine | OFFSIDES | ||
| 32 | Prednisone acetate | OFFSIDES | ||
| 33 | Terbutaline | OFFSIDES | ||
| 34 | abacavir | OFFSIDES | ||
| 35 | alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.